UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported):   July 21, 2008

 

MEDecision, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Pennsylvania

 

001-33191

 

23-2530889

(State or Other Jurisdiction of
Incorporation or Organization)

 

(Commission File Number)

 

(I.R.S. Employer Identification
Number)

 

 

 

 

 

601 Lee Road, Chesterbrook Corporate Center
Wayne, Pennsylvania

 

19087

(Address of Principal Executive Offices)

 

(Zip Code)

 

(610) 540-0202

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

 

Written communications pursuant to Rule 425 under the Securities Act

x

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

 

 



 

Item 8.01.  Other Events.

 

On July 21, 2008, MEDecision, Inc. (the “Company”) received notice that the United States Department of Justice and Federal Trade Commission have granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for the proposed merger (the “HCSC Merger”) between the Company and Health Care Service Corporation, a Mutual Legal Reserve Company, an Illinois corporation (“HCSC”).  The HCSC Merger remains subject to shareholder approval and other closing conditions set forth in the Agreement and Plan of Merger between the Company and HCSC dated June 17, 2008.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MEDECISION, INC.

 

 

 

 

Date: July 23, 2008

By:

/s/ Carl E. Smith

 

 

Name:

Carl E. Smith

 

 

Title:

Executive Vice President and Chief

 

 

 

Financial Officer

 

3


Medecision (MM) (NASDAQ:MEDE)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Medecision (MM) 차트를 더 보려면 여기를 클릭.
Medecision (MM) (NASDAQ:MEDE)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Medecision (MM) 차트를 더 보려면 여기를 클릭.